GSK PLC (GSK)
33.60
+0.25
(+0.75%)
USD |
NYSE |
Nov 21, 13:38
GSK Price to Book Value: 3.657 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.630 |
| November 19, 2024 | 3.642 |
| November 18, 2024 | 3.667 |
| November 15, 2024 | 3.630 |
| November 14, 2024 | 3.743 |
| November 13, 2024 | 3.821 |
| November 12, 2024 | 3.866 |
| November 11, 2024 | 3.956 |
| November 08, 2024 | 3.950 |
| November 07, 2024 | 3.99 |
| November 06, 2024 | 3.907 |
| November 05, 2024 | 4.029 |
| November 04, 2024 | 4.024 |
| November 01, 2024 | 4.014 |
| October 31, 2024 | 4.001 |
| October 30, 2024 | 4.028 |
| October 29, 2024 | 4.154 |
| October 28, 2024 | 4.123 |
| October 25, 2024 | 4.084 |
| October 24, 2024 | 4.108 |
| October 23, 2024 | 4.134 |
| October 22, 2024 | 4.136 |
| October 21, 2024 | 4.153 |
| October 18, 2024 | 4.196 |
| October 17, 2024 | 4.240 |
| Date | Value |
|---|---|
| October 16, 2024 | 4.268 |
| October 15, 2024 | 4.240 |
| October 14, 2024 | 4.259 |
| October 11, 2024 | 4.226 |
| October 10, 2024 | 4.268 |
| October 09, 2024 | 4.380 |
| October 08, 2024 | 4.138 |
| October 07, 2024 | 4.204 |
| October 04, 2024 | 4.225 |
| October 03, 2024 | 4.176 |
| October 02, 2024 | 4.294 |
| October 01, 2024 | 4.386 |
| September 30, 2024 | 4.449 |
| September 27, 2024 | 4.568 |
| September 26, 2024 | 4.589 |
| September 25, 2024 | 4.551 |
| September 24, 2024 | 4.598 |
| September 23, 2024 | 4.584 |
| September 20, 2024 | 4.578 |
| September 19, 2024 | 4.670 |
| September 18, 2024 | 4.760 |
| September 17, 2024 | 4.775 |
| September 16, 2024 | 4.886 |
| September 13, 2024 | 4.826 |
| September 12, 2024 | 4.837 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.935
Minimum
Sep 27 2022
7.596
Maximum
Dec 06 2022
4.686
Average
4.538
Median
Feb 07 2022
Price to Book Value Benchmarks
| AstraZeneca PLC | 4.867 |
| Pfizer Inc | 1.541 |
| Sanofi SA | 1.545 |
| Moderna Inc | 1.236 |
| Autolus Therapeutics PLC | 1.573 |
Price to Book Value Related Metrics
| PE Ratio | 21.84 |
| PS Ratio | 1.745 |
| Price to Free Cash Flow | 11.45 |
| Price | 33.60 |
| Earnings Yield | 4.58% |
| Market Cap | 68.55B |
| Operating PE Ratio | 12.22 |
| Normalized PE Ratio | 18.64 |